Wegovy (semaglutide) is a self-injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images

Injectable glucagon-like peptide-1 agonists, or GLP-1s, were first approved as diabetes medications 20 years ago. They’ve since become popular as weight loss drugs. Taken in conjunction with an appropriate diet and exercise regimen, GLP-1s are effective at lowering a person’s weight. Nonetheless, insurers in the commercial and public sectors have been reluctant to reimburse them as obesity medications. Policy analysts cite different reasons for payers holding back, including the drugs’ impact on ph

See Full Page